UCB7665
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for UCB7665, covering 2015-10-05 to 2024-01-29. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate Safety, Tolerability and Efficacy of UCB7665 in Subjects With Primary Immune Thrombocytopenia [Phase 2]